Anacor Pharmaceuticals, Inc. (ANAC)

[homebuilder_watcher]

Note today from Canaccord. Didn't help today but their theory is spot on I think raised target to $13.

Their timing was bad but logic sound. "Raising price target to $13 from $8 on Derm expert opinions on recent phase 2B data. We see ANAC's AN2728 for atopic dermatitis as a major value driver for shares going forward....After speaking to dermatologists on their opinions of the March AN2728, we believe there is major upside to our previous estimates. We have increased peak market share to 25% from 20%, as well as increasing AN2728's chance of success from 40 to 50%. Dermatologogists we have spoken with think there is a strong suggestion that AN2728 could be stronger than Elidel and Protopic...phase 2B strongly suggests that AN2728 results in more symptoms relief...